Surface-enhanced Raman spectroscopy of serum accurately detects prostate cancer in patients with prostate-specific antigen levels of 4–10 ng/mL

The surface-enhanced Raman spectroscopy (SERS) of blood serum was investigated to differentiate between prostate cancer (PCa) and benign prostatic hyperplasia (BPH) in males with a prostate-specific antigen level of 4–10 ng/mL, so as to reduce unnecessary biopsies. A total of 240 SERS spectra from b...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Na, Rong, Ming, Shao, Xiaoguang, Zhang, Heng, Liu, Shupeng, Dong, Baijun, Xue, Wei, Wang, Tingyun, Li, Taihao, Pan, Jiahua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538684/
https://www.ncbi.nlm.nih.gov/pubmed/28794631
http://dx.doi.org/10.2147/IJN.S137756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538684/
https://www.ncbi.nlm.nih.gov/pubmed/28794631
http://dx.doi.org/10.2147/IJN.S137756

Ejemplares similares